For a better understanding of protein synthesis and degradation in the
human kidney, the arteriovenous difference technique across the kidne
y, splanchnic organs, and leg muscle was combined with labeled leucine
and phenylalanine isotope dilution models. Results indicate that in t
he postabsorptive state, the protein balance across the human kidney i
s negative because the rate of leucine release from protein degradatio
n is greater than the amount used for protein synthesis. In the splanc
hnic bed, net protein balance is neutral since the amount of leucine d
eriving from protein degradation is similar to the amount utilized for
protein synthesis. In the leg muscle, protein degradation exceeds pro
tein synthesis. The kidney exhibits the highest leucine metabolic acti
vity when expressed in terms of total organ leucine content. The estim
ated fractional protein synthesis rate in the human kidney is about 40
% per day (vs. about 2% in muscle and 12% in the splanchnic bed). The
human kidney presents high rates of protein turnover and accounts for
a significant fraction of whole-body protein degradation, protein synt
hesis, and leucine oxidation.